100 related articles for article (PubMed ID: 3129979)
1. [Vasobral and stabilized cerebral vascular complication: hemodynamic and psychometric study].
Poncin-Lafitte M; Migeon P; Rancurel G; Rapin JR
Ann Radiol (Paris); 1987; 30(6):425-30. PubMed ID: 3129979
[No Abstract] [Full Text] [Related]
2. [Efficacy of the combination drug vasobral in chronic vascular encephalopathy].
Levin OS; Barantsevich ER; Belskaya GN; Vasenina EE; Kopishinskaya SV; Lukashevich IG; Ostroumova OD; Psokhina OV; Radiuk MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):25-9. PubMed ID: 25591512
[TBL] [Abstract][Full Text] [Related]
3. [The influence of alpha-dihydroergocryptine derivatives on psychomotor manifestations in Parkinson disease].
Sadekov RA
Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):43-5. PubMed ID: 11195537
[TBL] [Abstract][Full Text] [Related]
4. [Experience in the administration of vasobral in sensorineural vascular hypoasusis].
Grinshteĭn AB; Shnaĭder NA; Kromm OK; Pavlovskaia MV
Vestn Otorinolaringol; 2001; (2):39-41. PubMed ID: 11338557
[TBL] [Abstract][Full Text] [Related]
5. [Vasobral in the treatment of brain lesions: views of physicians and patients].
Kamchatnov PR
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):23-5. PubMed ID: 23528488
[TBL] [Abstract][Full Text] [Related]
6. [Vasobral in the treatment of initial atherosclerotic circulatory encephalopathy].
Shprakh VV; Molokov DD; Tatarinova MB; Burdukovskaia NL
Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(2):39-40. PubMed ID: 8754338
[No Abstract] [Full Text] [Related]
7. [Preventive treatment of migraine with vasobral: a multicenter trial].
Tabeeva GR; Azimova IuE
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 2):26-30. PubMed ID: 21389936
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of chronic cerebrovascular insufficiency. Controlled comparative study of 2 cerebral antihypoxidosis agents].
Szobor A; Klein M; Bräuer H
MMW Munch Med Wochenschr; 1982 Oct; 124(41):897-900. PubMed ID: 6815511
[No Abstract] [Full Text] [Related]
9. [Disorders of cerebral hemodynamics and their correction in epilepsy].
Shutov AA; Pleshkova NM; Shestakov VV
Sov Med; 1979 Jul; (7):35-9. PubMed ID: 505126
[No Abstract] [Full Text] [Related]
10. [Use of vasobral in therapy of central nervous system pathology in children of early age].
Zaĭtseva IN
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):92-4. PubMed ID: 20614656
[No Abstract] [Full Text] [Related]
11. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P
Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
[TBL] [Abstract][Full Text] [Related]
12. [Review of certain antagonists of peroxidation of membrane lipids by free radicals in the therapy of acute cerebrovascular accidents of ischemic origin].
Cahn J; Borzeix MG; Akimjak JP; Angignard J; Labos M; Lebeau M
Agressologie; 1982; 23(C):21-9. PubMed ID: 6812445
[No Abstract] [Full Text] [Related]
13. [Clinico-rheographic study of the cerebrovascular effect of alpha-adrenergic blockers in vascular diseases of the brain].
Shtok VN; Varlamova IV; Fedorova NV; Timurbaator
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1333-8. PubMed ID: 4072531
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the effectiveness of dihydroergotoxine (DHET) in the treatment of chronic cerebral ischemia syndromes in elderly patients].
Derejczyk J; Panuś K
Wiad Lek; 1986 Jun; 39(12):818-24. PubMed ID: 3535261
[No Abstract] [Full Text] [Related]
15. [Careful treatment of hypertension in the elderly. A multicenter medical practice study with Ergodesit Spezial].
Daunderer W
Fortschr Med; 1985 Jul; 103(25):680-2. PubMed ID: 4029863
[No Abstract] [Full Text] [Related]
16. [Quantitative rheographic study of the effects of a new drug combination: raubasine/dihydroergocristine].
Henriet M; Jacquy J; Noel G
Brux Med; 1974 Dec; 54(12):743-5. PubMed ID: 4215548
[No Abstract] [Full Text] [Related]
17. [Therapeutic effectiveness and safety of dihydroergocristine. A study of 9,702 patients].
Mailland F; Zottino G
Fortschr Med; 1986 Mar; 104(11):239-42. PubMed ID: 3084366
[No Abstract] [Full Text] [Related]
18. Evaluation of cerebrovascular processes and their reactions to pharmacotherapy by means of ultrasonic methods.
Klein K; Klein M; Klein P
Z Alternsforsch; 1985; 40(6):369-74. PubMed ID: 2934900
[TBL] [Abstract][Full Text] [Related]
19. [Trials in the treatment of cerebrovascular insufficiency with the monodrug dihydroergocristine. A multicentric study].
Finke J; Haehn KD; Haase W
Med Welt; 1982 Jul; 33(28):1042-7. PubMed ID: 6811832
[No Abstract] [Full Text] [Related]
20. [Assessment of quality of life and treatment adherence in patients with dizziness treated with vasobral].
Lebedeva AV; Kamchatnov PR; Burd SG; Prikazchikov SV; Cherkasova AE; Solovyeva TY
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(2):28-34. PubMed ID: 30874523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
